The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...
Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.
Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs.
Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...
Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body already produces called glucagon-like peptide-1 (GLP-1), which helps regulate ...